Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Director departure
Appointed director
GeoVax Labs, Inc. (GOVX) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 4 McKee Kelly T. Jr. (Chief Medical Officer) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Bought 9,653 shares @ $0.52, valued at $5k
08/22/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/21/2023 4 Reynolds Mark (CFO) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Bought 10,000 shares @ $0.5179, valued at $5.2k
08/14/2023 4 SPENCER JOHN N JR (Director) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 50,000 options @ $0.755, valued at $37.8k
08/14/2023 4 Morgan Jayne (Director) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 50,000 options @ $0.755, valued at $37.8k
08/14/2023 4 MCNALLY ROBERT T (Director) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 50,000 options @ $0.755, valued at $37.8k
08/14/2023 4 Lemerond Nicole (Director) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 50,000 options @ $0.755, valued at $37.8k
08/14/2023 4 Kollintzas Dean G (Director) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 50,000 options @ $0.755, valued at $37.8k
08/14/2023 4 CHASE RANDAL D (Director) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 50,000 options @ $0.755, valued at $37.8k
08/14/2023 4 McKee Kelly T. Jr. (Chief Medical Officer) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 15,000 options @ $0.755, valued at $11.3k
08/14/2023 4 Sharkey John W. (VP, Business Development) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 100,000 options @ $0.755, valued at $75.5k
08/14/2023 4 NEWMAN MARK J (Chief Scientific Officer) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 100,000 options @ $0.755, valued at $75.5k
08/14/2023 4 DODD DAVID A (President, CEO) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 250,000 options @ $0.755, valued at $188.8k
08/14/2023 4 Reynolds Mark (CFO) has filed a Form 4 on GeoVax Labs, Inc.
Txns: Granted 100,000 options @ $0.755, valued at $75.5k
08/10/2023 8-K Quarterly results
Docs: "GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update"
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/18/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: " ",
" "
07/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/12/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/12/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
05/05/2023 8-K Quarterly results
Docs: "GeoVax Reports 2023 First Quarter Financial Results and Provides Corporate Update"
05/04/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/04/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/04/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/27/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/27/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/27/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/24/2023 8-K Quarterly results
Docs: "GeoVax Reports 2022 Year-End Financial Results And Provides Corporate Update"
03/23/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy